{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:58:29Z","timestamp":1782979109872,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.drugalcdep.2015.03.036","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T19:53:07Z","timestamp":1428781987000},"page":"218-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003"],"prefix":"10.1016","volume":"152","author":[{"given":"Celestina","family":"Barbosa-Leiker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sterling","family":"McPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Rose","family":"Mamey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Leonard","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Roll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0376-8716(99)00074-5","article-title":"Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet","volume":"58","author":"Amass","year":"2000","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jsat.2013.08.020","article-title":"Measurement invariance of the adjective rating scale for withdrawal across treatment groups, gender, and over time","volume":"46","author":"Barbosa-Leiker","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0015","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/clpt.1988.13","article-title":"A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts","volume":"43","author":"Bickel","year":"1988","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3565(25)20047-7","article-title":"Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans","volume":"247","author":"Bickel","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0025","series-title":"Confirmatory Factor Analysis For Applied Research","author":"Brown","year":"2006"},{"issue":"1","key":"10.1016\/j.drugalcdep.2015.03.036_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.111.186874","article-title":"Pleiotropic opioid regulation of spinal endomorphin 2 release and its adaptations to opioid withdrawal are sexually dimorphic","volume":"340","author":"Chakrabarti","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0050","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.pbb.2008.05.023","article-title":"Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis","volume":"90","author":"Chopra","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0055","series-title":"Structural Equation Modeling, A Second Course","article-title":"Nonnormal and categorical data in structural equation modeling","author":"Finney","year":"2013"},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0060","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.yfrne.2012.09.004","article-title":"Importance of sex to pain and its amelioration; relevance of spinal estrogens and its membrane receptors","volume":"33","author":"Gintzler","year":"2012","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0065","series-title":"An Easy Guide To Factor Anlaysis","author":"Kline","year":"1994"},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0070","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1360-0443.2005.01154.x","article-title":"A mulit-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network","volume":"100","author":"Ling","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0075","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1360-0443.2008.02455.x","article-title":"Buprenorphine tapering schedule and illicit opioid use","volume":"104","author":"Ling","year":"2009","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0080","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hup.2339","article-title":"Longitudinal missing data strategies for substance use clinical trials using generalized estimating equations: an example with a buprenorphine trial","volume":"28","author":"McPherson","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0085","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/a0027146","article-title":"Missing data in substance research: current methods and modern approaches","volume":"20","author":"McPherson","year":"2012","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0090","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.drugalcdep.2009.07.001","article-title":"Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument","volume":"105","author":"Tompkins","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0100","series-title":"Evaluating Cutoff Criteria of Model Fit Indices for Latent Variables Models with Binary and Continuous Outcomes","author":"Yu","year":"2002"},{"key":"10.1016\/j.drugalcdep.2015.03.036_bib0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2008.06.016","article-title":"Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network","volume":"99","author":"Ziedonis","year":"2009","journal-title":"Drug Alcohol Depend."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615001921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871615001921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T11:24:31Z","timestamp":1747913071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871615001921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":18,"alternative-id":["S0376871615001921"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.03.036","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.03.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}